Latest 10-K annual reports

QuoteMedia's 2024 annual report reveals a slight revenue decrease but outlines plans for product expansion and infrastructure upgrades in 2025.

Dominari Holdings Inc. reports its 2024 annual results, highlighting a shift in focus towards financial services and strategic initiatives in the AI and data center sectors.

Eline Entertainment Group's 10-K filing reveals ongoing losses and a search for a merger or acquisition target, raising concerns about the company's ability to continue as a going concern.

Cluster Group Holdings Limited Co. (CLUS) files its annual report on Form 10-K, detailing its plans to pursue a merger or acquisition in the food industry and reporting a net loss of $58,459 for the year ended December 31, 2024.

Spindletop Oil & Gas Co.'s 2024 10-K filing reveals a decrease in oil and gas revenues amid fluctuating commodity prices, while the company continues to explore strategic alternatives to enhance shareholder value.

Bravo Multinational Inc.'s FY 2024 results reveal no revenue, a net loss, and substantial doubt about its ability to continue as a going concern.

Zhen Ding Resources Inc.'s 10-K filing reveals continued efforts to secure financing and resume mining operations at its Chinese joint venture, while facing ongoing financial challenges.

Clean Vision Corporation reports its fiscal year 2024 results, highlighting its focus on clean technology and sustainability opportunities within the clean energy and waste-to-value industries.

Byrn Inc., a dormant shell company, filed its annual report on Form 10-K, outlining its current state and future plans to explore potential business opportunities.

SEATech Ventures Corp. reported no revenue for the fiscal year ended December 31, 2024, citing adverse economic conditions and a cancelled acquisition, while also disclosing material weaknesses in internal controls.

BioNexus Gene Lab Corp. announces its fiscal year 2024 results, highlighting a strong liquidity position, strategic innovation initiatives, and proactive governance enhancements while addressing Nasdaq compliance challenges.

Lucent Inc.'s latest filing reveals a $95.2 million asset valuation as of December 31, 2024, primarily attributed to the mineral resource potential of its gold and graphite mining projects in Mexico.

Vanjia Corporation's 2024 10-K filing reveals a net loss but outlines plans for affordable housing development in Houston, supported by a director's line of credit.

Baltic International USA, Inc. files its annual report on Form 10-K, highlighting its ongoing efforts to identify and acquire a target company while navigating minimal assets and a history of operating losses.

Hyperscale Data, Inc. files its 10-K report for fiscal year 2024, detailing financial results and a strategic pivot from Bitcoin mining to AI and high-performance computing.

BranchOut Food Inc.'s 2024 annual report reveals a year of strategic expansion, including the launch of a new production facility in Peru, alongside ongoing financial challenges and a net loss of $4.75 million.

SS Innovations International's 2024 10-K filing reveals a significant revenue increase driven by surgical robotic system sales, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and dependence on external funding.

MediaCo Holding Inc.'s 2024 10-K filing highlights the impact of the Estrella Acquisition on revenue growth and strategic focus on multicultural audiences.

Constellium SE files an amendment to its 2024 Annual Report on Form 10-K, updating information on executive compensation, security ownership, and the equity incentive plan.

GeoSolar Technologies, still in its development stage, reports a net loss of $1.54 million for 2024 while initiating revenue generation through its SmartGreen Home system.

New Momentum Corporation's 10-K filing reveals a net loss for 2024 and expresses substantial doubt about the company's ability to continue as a going concern.

Adverum Biotechnologies' 10-K filing reveals substantial doubt about its ability to continue as a going concern due to recurring losses, a material weakness in internal controls, and the need for additional funding.

Spruce Biosciences reports significant net losses and raises substantial doubt about its ability to continue as a going concern despite advancements in its clinical development programs.

GivBux Inc.'s 2024 10-K filing highlights a significant increase in revenue driven by transactional and subscription growth, alongside a substantial net loss due to increased operating expenses and stock-based compensation.

Koil Energy Solutions, Inc. reports a 48% increase in revenue for 2024, driven by fixed price contracts, but identifies material weaknesses in internal control over financial reporting.

Blaize Holdings, Inc. files its 2024 10-K, detailing its business strategy, financial performance, and risk factors following its merger with BurTech Acquisition Corporation.

IMAC Holdings transitions to proteomic services, acquiring Theralink assets, while grappling with Nasdaq delisting due to Minimum Equity Rule non-compliance.

Applied Therapeutics receives a Complete Response Letter from the FDA for its Galactosemia drug, prompting a strategic shift towards Sorbitol Dehydrogenase (SORD) Deficiency treatment.

Yunhong Green CTI Ltd.'s 2024 Form 10-K reveals strategic shifts, financial challenges, and efforts to maintain NASDAQ listing compliance.

Pioneer Power Solutions reports a significant increase in revenue for its Critical Power segment, driven by mobile EV charging solutions, despite identifying a material weakness in internal controls.